Matts Johansen is the CEO of Aker BioMarine, the global leader in krill fishing and production of krill-based products, such as omega 3 supplements and aquaculture feed. Aker BioMarine was founded as part of the Aker conglomerate, and Matts has been the CEO since 2015. In July 2020, they listed the company on Euronext Growth Oslo, in the middle of covid. They then up-listed it to the main exchange in 2021. With Matts, we discuss his experience of listing an innovative company with few listed peers in Europe, a very rapid IPO process during covid, and how to maintain a long-term focus even after listing. On the way, we will learn a lot of details about krill, a very interesting nutrient source at the bottom of the food pyramid. Disclaimer: this discussion is not financial advice, nor an investment recommendation, nor a solicitation to buy or sell any financial instruments, or an offer for financial services or any other transaction. The information contained in the recording have no contractual value and are destined for an informational purpose only. Amundsen Investment Management and the participants on this podcast may have holdings in the companies being discussed.